在儿科心脏病学中用于血管的可吸收金属支架:进展和前景
Daniel I McLennan1, Jennifer R Maldonado1, Susan R Foerster1
1Department of Pediatrics-Division of Cardiology, Herma Heart Institute, Children's Wisconsin and the Medical College of Wisconsin, Milwaukee, WI, United States.
Frontiers in cardiovascular medicine
|August 21, 2024
概括
完全可吸收的金属支架显示出治疗儿科血管疾病的前景,但目前的设备未能达到降解基准. 未来的工程是必要的,以提高先天性心脏病患者的性能.
科学领域:
- 生物材料科学 生物材料科学
- 心血管工程 心血管工程
- 儿童心脏病学 儿童心脏病学
背景情况:
- 完全可吸收的金属支架在治疗血管狭窄症方面取得了重大进展.
- 这些设备旨在消除长期并发症,并促进未来的干预.
- 这种需要在患有先天性心脏病 (CHD) 的儿科患者中尤其严重.
研究的目的:
- 审查可完全吸收金属支架的理论和最近的临床应用.
- 讨论当前一代可吸收金属支架在心脏病患者中的挑战和经验.
- 提出工程改进的未来方向.
主要方法:
- 关于可吸收金属支架技术和临床使用的文献综述.
- 自2019年以来,对儿科心脏病的最新临床数据的分析.
- 讨论机构经验和挑战.
主要成果:
- 商业上可用的可吸收金属支架已在儿科心脏病患者中用于各种疾病.
- 短期的程序成功是常见的,但设备往往无法达到所需的降解基准.
- 设备性能和特定应用程序的退化仍然存在挑战.
结论:
- 目前的可吸收金属支架提供了潜在的好处,但尚未达到CHD的性能预期.
- 进一步的工程创新对于优化降解概况和临床结果至关重要.
- 未来的研究应该专注于减轻改善患者护理的现有挑战.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


